Supplier
Cocke County Hma, LLC
Cocke County Hma, LLC was paid $18.34M by Medicaid between Jan 2018 and Dec 2024, across 109 billing codes. Its largest line is 99283, emergency room visit (moderate) — 42% of everything it billed.
33Billing provider infoCOCKE COUNTY HMA, LLC
NEWPORT, TN 37821
NEWPORT, TN 37821
33aNPI1972576247assigned 02/08/2006
33bProvider typeLong Term Care Pharmacy
28Total paid$18.34M
24GClaims393,609
24DCodes billed109
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Long Term Care Pharmacy providers in Tennessee
Rank by total paid#2 of 8
Median peer was paid$19.36
This provider vs. median947,431×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 60,760 | $2.74M | |
| 2019 | 64,407 | $2.73M | |
| 2020 | 50,004 | $2.15M | |
| 2021 | 46,269 | $2.74M | |
| 2022 | 52,404 | $2.79M | |
| 2023 | 72,260 | $3.07M | |
| 2024incomplete | 47,505 | $2.12M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 42% | 43,191 | 36,986 | $7.69M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 23,153 | 19,220 | $5.13M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 9,179 | 7,138 | $2.11M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.4% | 8,535 | 7,510 | $801K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.4% | 2,132 | 1,527 | $446K |
| 87428 | 2.3% | 10,581 | 9,473 | $426K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.9% | 4,318 | 3,855 | $341K |
| G0378 | Hospital observation service, per hour | 1.6% | 2,592 | 1,916 | $299K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 11,865 | 9,533 | $138K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 10,466 | 8,046 | $121K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 32,379 | 23,496 | $74K |
| 84484 | <1% | 12,614 | 7,492 | $59K |
97 more codes
| 80053 | Comprehensive metabolic panel | <1% | 29,001 | $55K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 11,115 | $51K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,399 | $46K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 7,209 | $44K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 157 | $43K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,650 | $37K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,262 | $35K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 14,518 | $32K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,655 | $32K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 540 | $28K |
| 36415 | Collection of venous blood by venipuncture | <1% | 39,250 | $27K |
| 71045 | Radiologic examination, chest; single view | <1% | 9,923 | $26K |
| 87081 | <1% | 8,894 | $24K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,523 | $24K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 555 | $23K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,487 | $18K |
| 83690 | <1% | 6,542 | $16K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 577 | $16K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 879 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 283 | $10K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,828 | $9K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,894 | $9K |
| 43450 | <1% | 80 | $9K | |
| 85027 | <1% | 4,490 | $8K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,154 | $8K |
| 81001 | <1% | 14,634 | $8K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,129 | $8K |
| 81025 | <1% | 2,854 | $6K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 16 | $5K |
| 45384 | <1% | 15 | $4K | |
| 83735 | <1% | 3,156 | $4K | |
| 87040 | <1% | 1,548 | $4K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 296 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,145 | $4K |
| 83880 | <1% | 880 | $3K | |
| 86140 | <1% | 1,354 | $2K | |
| 83605 | <1% | 874 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 570 | $2K |
| 84702 | <1% | 119 | $1K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 15 | $1K |
| 96376 | <1% | 339 | $1K | |
| 85610 | <1% | 1,120 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 681 | $1K |
| 85379 | <1% | 282 | $966.29 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,223 | $956.95 |
| 82962 | <1% | 600 | $900.77 | |
| 85730 | <1% | 403 | $687.70 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 87 | $678.80 |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | <1% | 13 | $609.96 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 136 | $604.80 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 42 | $566.12 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 61 | $515.37 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,240 | $477.35 |
| 87807 | <1% | 108 | $401.35 | |
| 94760 | <1% | 476 | $372.12 | |
| 82550 | <1% | 197 | $355.11 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,693 | $330.75 |
| 80061 | Lipid panel | <1% | 152 | $311.96 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 56 | $298.90 |
| 73630 | <1% | 69 | $291.27 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,900 | $273.15 |
| 82150 | <1% | 121 | $251.10 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 109 | $206.72 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,964 | $197.07 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,604 | $172.34 |
| 73610 | <1% | 45 | $152.46 | |
| 82077 | <1% | 64 | $129.67 | |
| 87186 | <1% | 45 | $118.79 | |
| 73130 | <1% | 14 | $91.98 | |
| 73110 | <1% | 12 | $76.65 | |
| 87077 | <1% | 58 | $73.65 | |
| 73030 | <1% | 12 | $48.90 | |
| 73562 | <1% | 16 | $48.90 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 107 | $44.87 |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 14 | $41.49 |
| 72100 | <1% | 13 | $38.26 | |
| 88342 | <1% | 1,091 | $30.89 | |
| 82553 | <1% | 23 | $19.52 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 282 | $18.16 |
| 80179 | <1% | 16 | $16.96 | |
| 80143 | <1% | 17 | $16.96 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 67 | $9.55 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 17 | $6.08 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 20 | $5.71 |
| 81003 | <1% | 16 | $3.58 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 15 | $1.26 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 16 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 16 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 16 | $0.00 |
| 88313 | 0% | 12 | $0.00 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 0% | 16 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 3,312 | $0.00 |
| 94761 | 0% | 33 | $0.00 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 12 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 14 | $0.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 16 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.